These data also suggest FAO inhibitors might sensitize HK1−HK2+ cancer cells to the combination of DPI and HK2 inhibition but could be tolerated by HK4-expressing hepatocytes and by other normal tissues which express HK1. This evidence concerns the gene HK1 and cancer.